Literature DB >> 23021929

Menopausal symptoms and the risk of young-onset breast cancer.

Chunyuan Fei1, Lisa A DeRoo, Dale P Sandler, Clarice R Weinberg.   

Abstract

BACKGROUND: Women with menopausal symptoms have been reported to have reduced risk of breast cancer, possibly reflecting differences in endogenous hormone levels. We examined the associations between menopausal symptoms and breast cancer in women under age 50.
METHODS: We carried out a sister-controlled case-control study, the Two Sister Study, comparing 1422 women with breast cancer diagnosed before age 50 and their 1669 sisters who were free of breast cancer and had enrolled in the prospective Sister Study cohort. History and age at first occurrence of menopause-associated symptoms (e.g. hot flashes, poor sleep or night sweats) were ascertained using computer-assisted telephone interviews. To equalise opportunity for exposure, we assessed exposures in relation to a sibship-based index age (the minimum of the age at diagnosis of the case sister and the age at interview of her control sister(s)), and estimated odds ratios using conditional logistic regression with adjustment for menopausal status and birth order.
FINDINGS: Having had menopause-associated symptoms (n=706) prior to the index age was associated with reduced risk of young-onset breast cancer (odds ratio (OR), 0.49; 95% confidence interval (CI), 0.40-0.61). Similar results were seen for hot flashes and for "other" menopausal symptoms. The association between menopausal symptoms and breast cancer risk was somewhat stronger for oestrogen receptor positive tumours than for oestrogen receptor negative tumours (heterogeneity p=0.07). Menopausal status, age at menopause, BMI and hormone replacement therapy did not modify the associations, but the inverse association between menopausal symptoms and breast cancer attenuated with increasing index age (p<0.01).
INTERPRETATION: Menopause-associated symptoms were associated with markedly reduced risk of young-onset breast cancer. Further studies are needed to confirm the association and elucidate possible pathways. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23021929      PMCID: PMC3552002          DOI: 10.1016/j.ejca.2012.08.030

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Fertility drugs and young-onset breast cancer: results from the Two Sister Study.

Authors:  Chunyuan Fei; Lisa A Deroo; Dale P Sandler; Clarice R Weinberg
Journal:  J Natl Cancer Inst       Date:  2012-07-06       Impact factor: 13.506

2.  Effect of hormone metabolism genotypes on steroid hormone levels and menopausal symptoms in a prospective population-based cohort of women experiencing the menopausal transition.

Authors:  Timothy R Rebbeck; H Irene Su; Mary D Sammel; Hui Lin; Teo V Tran; Clarisa R Gracia; Ellen W Freeman
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

3.  Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study.

Authors:  Nancy F Woods; Ellen Sullivan Mitchell; Yun Tao; Hannah-Malia A Viernes; Patricia L Stapleton; Federico M Farin
Journal:  Menopause       Date:  2006 Nov-Dec       Impact factor: 2.953

4.  Hot flashes: behavioral treatments, mechanisms, and relation to sleep.

Authors:  Robert R Freedman
Journal:  Am J Med       Date:  2005-12-19       Impact factor: 4.965

Review 5.  Hormonal changes during menopause.

Authors:  Farook Al-Azzawi; Santiago Palacios
Journal:  Maturitas       Date:  2009-04-15       Impact factor: 4.342

Review 6.  Meta- and pooled analyses of the cytochrome P-450 1B1 Val432Leu polymorphism and breast cancer: a HuGE-GSEC review.

Authors:  Valentina Paracchini; Sara Raimondi; Inger T Gram; Daehee Kang; Neslihan A Kocabas; Vessela N Kristensen; Donghui Li; Fritz F Parl; Tove Rylander-Rudqvist; Pavel Soucek; Wei Zheng; Sara Wedren; Emanuela Taioli
Journal:  Am J Epidemiol       Date:  2006-10-19       Impact factor: 4.897

7.  Genetic polymorphisms, hormone levels, and hot flashes in midlife women.

Authors:  Chrissy Schilling; Lisa Gallicchio; Susan R Miller; Patricia Langenberg; Howard Zacur; Jodi A Flaws
Journal:  Maturitas       Date:  2006-12-21       Impact factor: 4.342

8.  Relationship between menopausal symptoms and risk of postmenopausal breast cancer.

Authors:  Yi Huang; Kathleen E Malone; Kara L Cushing-Haugen; Janet R Daling; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-06       Impact factor: 4.254

9.  Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women.

Authors:  Kala Visvanathan; Lisa Gallicchio; Chrissy Schilling; Janice K Babus; Lynn M Lewis; Susan R Miller; Howard Zacur; Jodi A Flaws
Journal:  Obstet Gynecol       Date:  2005-12       Impact factor: 7.661

10.  Measuring hot flashes: summary of a National Institutes of Health workshop.

Authors:  Heather G Miller; Rose Maria Li
Journal:  Mayo Clin Proc       Date:  2004-06       Impact factor: 7.616

View more
  5 in total

1.  Hormone therapy and young-onset breast cancer.

Authors:  Katie M O'Brien; Chunyuan Fei; Dale P Sandler; Hazel B Nichols; Lisa A DeRoo; Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2015-02-18       Impact factor: 4.897

2.  Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation.

Authors:  Vicki Hart; Susan R Sturgeon; Nicholas Reich; Lynnette Leidy Sievert; Sybil L Crawford; Ellen B Gold; Nancy E Avis; Katherine W Reeves
Journal:  Cancer Causes Control       Date:  2016-09-28       Impact factor: 2.506

3.  Temporal trend, clinicopathologic and sociodemographic characterization of age at diagnosis of breast cancer among US women diagnosed from 1990 to 2009.

Authors:  Gabriel Escarela; Luis Carlos Pérez-Ruiz; Gabriel Núñez-Antonio
Journal:  Springerplus       Date:  2014-10-23

4.  Long-Term Cause-Specific Mortality After Surgery for Women With Breast Cancer: A 20-Year Follow-Up Study From Surveillance, Epidemiology, and End Results Cancer Registries.

Authors:  Gabriel Escarela; Alan Jiménez-Balandra; Gabriel Núñez-Antonio; Antonio Gordillo-Moscoso
Journal:  Breast Cancer (Auckl)       Date:  2017-06-01

5.  Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial.

Authors:  Michael J Hale; Anthony Howell; Mitch Dowsett; Jack Cuzick; Ivana Sestak
Journal:  Breast       Date:  2020-10-31       Impact factor: 4.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.